EGFR and cancer: The staining intensity of EGFR was higher in subgroups of adenomas (grade 2–3: 87.1%) and cancers (grade 2–3: 100%), compared to hyperplastic polyps (max: grade 2) and control group (max: grade 2: 7.5% to 34%) (p < 0.0001).